1. Effectiveness of tirofiban for failed thrombolysis during acute myocardial infarction
- Author
-
Angela Martone, Alfredo Vetrano, Fabrizio Corsini, Margherita Schioppa, Saverio Melorio, Salvatore Romano, Francesca Sideri, Raffaele Carotenuto, Carmelo Chieffo, and Corsini G
- Subjects
Male ,medicine.medical_specialty ,Heart disease ,medicine.medical_treatment ,Myocardial Infarction ,Platelet Glycoprotein GPIIb-IIIa Complex ,Fibrinolytic Agents ,Internal medicine ,Fibrinolysis ,medicine ,Humans ,Thrombolytic Therapy ,Treatment Failure ,cardiovascular diseases ,Myocardial infarction ,Aged ,business.industry ,Thrombolysis ,Tirofiban ,Middle Aged ,medicine.disease ,Rescue treatment ,Tissue Plasminogen Activator ,Retreatment ,Circulatory system ,Cardiology ,Feasibility Studies ,Tyrosine ,Female ,Myocardial disease ,Cardiology and Cardiovascular Medicine ,business ,medicine.drug - Abstract
The clinical outcome of 48 consective patients with myocardial infarction who received tirofiban for unsuccessful thrombolysis was compared with that of 48 patients matched for age, gender, and infarct location who did not receive rescue treatment. Those who received tirofiban had more successful reperfusions, and there were few bleeding complications.
- Published
- 2004
- Full Text
- View/download PDF